Get Personal
Introduction
Colorectal cancer is the third most commonly diagnosed cancer in Canada and nearly 50% of diagnoses are in late stages. The 5-year survival rate for those at Stage IV is less than 15%. While recent advances in molecular profiling have started to improve the way in which optimal treatments are matched to metastatic cancer patients of various disease sites, access to testing varies by provinces.
To address the unmet needs of metastatic colorectal cancer (mCRC) and other metastatic cancer patients across Canada, Colorectal Cancer Canada (CCC) is proposing the Get Personal Campaign to educate patients and inform health policy about molecular profiling for use with companion diagnostics to increase access to personalized healthcare and precision medicine based on a patient’s specific genetic profile.
The mission of Colorectal Cancer Canada’s Get Personal Campaign is to raise awareness and advocate for timely reflex biomarker testing to ensure the most appropriate personalized treatment plan is developed according to the genomic makeup of a patient’s tumour and personal set of disease characteristics.
Colorectal Cancer Canada envisions a future in which metastatic cancer patients are aware of their molecular profiles and have access to personalized treatment plans which prolong or improve their quality of life.
Key Activities
Resources & Downloads
Understanding Biomarker Testing with Dr. Sheffield
What is the difference between genetic and biomarker testing?
